GenEdit Alternatives & Competitors
12 companies similar to GenEdit — Delivering the potential of genetic medicines
Mnemo Therapeutics
Empower the body, cure the disease
Paris, France
AskBio Inc.
Pioneering science to create transformative molecular medicines.
United States
Adaptimmune
Designing and delivering cell therapies to transform the lives of people with cancer.
Abingdon, United Kingdom
Transition Bio, Inc.
The only end-to-end condensate drug discovery platform built on molecular insights.
Cambridge, United States
Track all GenEdit competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Outpace Bio
Revolutionizing Cell Therapy with Protein Design
Seattle, United States
Adaptive Biotechnologies Corp.
Every immune system has a story to tell; the key is knowing how to listen.
Seattle, United States
Guardant Health
Conquering Cancer With Data
Palo Alto, United States
Adagene
Redefining the design and discovery of therapeutic antibodies
Tay Therapeutics Ltd
Science that matters. Therapies that deliver.
Dundee, United Kingdom
Acrigen Biosciences
Developing life-saving genetic therapies using our proprietary precision gene editing tech...
Alameda, United States
Imvax, Inc.
Imvax is a clinical-stage biotechnology company developing personalized, whole tumor-deriv...
Philadelphia, United Stat...
Amphista Therapeutics Limited
A new approach to targeted protein degradation to bring life-changing medicines to patient...
Cambridge, United Kingdom
About GenEdit
Delivering the potential of genetic medicines
Development of Precision Genetic Medicines, Targeted Delivery of Genetic Payloads, Restoration of Immune Balance, Pipeline for Autoimmune and Oncology Therapies
Patients with Autoimmune Diseases, Healthcare Providers, Biotechnology Researchers, Pharmaceutical Companies
Genetic Medicines, Gene Therapy Delivery, Polymer Nanoparticles, Non-Viral Gene Editing, Therapeutic Candidates, NanoGalaxy Platform, Target Tissue Delivery, Gene Therapy Innovation, Non-Lipid Nanoparticles, Therapeutic Gene Editing, High Unmet Medical Need, Iterative Screening Process, Non-Viral Therapeutics, Genetic Disease Treatment, Safer Gene Editing
B2B, Platform
Licensing, Project Based, Service Fee
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches GenEdit and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at GenEdit on 15 Jun 2026. The 12 companies listed here were last checked between 17 Sep 2025 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.